Clinical and Cytogenetic Profiles of Rhabdomyosarcoma with Bone Marrow Involvement in Korean Children: A 15-Year Single-Institution Experience

키워드

참고문헌 (17)

1. Punyko JA, "Long-term survival probabilities for childhood rhabdomyosarcoma. A population-based evaluation", Cancer, 103, pp.1475~1483 (2005)[DOI]
2. Barr FG, "Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group", Genes Chromosomes Cancer, 48, pp.661~672 (2009)[DOI]
3. Agamanolis DP, "Tumors of skeletal muscle", Hum Pathol, 17, pp.778~795 (1986)[DOI]
4. Sangkhathat S, "Current management of pediatric soft tissue sarcomas", World J Clin Pediatr, 4, pp.94~105 (2015)[DOI]
5. Vleeshouwer-Neumann T, "Histone deacetylase inhibitors antagonize distinct pathways to suppress tumorigenesis of embryonal rhabdomyosarcoma", PLoS One, 10, pp.e0144320~ (2015)[DOI]
6. Goldstein M, "Novel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumors", Neoplasia, 8, pp.332~343 (2006)[DOI]
7. Sorensen PH, "PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group", J Clin Oncol, 20, pp.2672~2679 (2002)[DOI]
8. Slater O, "Clinical relevance of molecular genetics to paediatric sarcomas", J Clin Pathol, 60, pp.1187~1194 (2007)[DOI]
9. Krskova L, "Detection and clinical significance of bone marrow involvement in patients with rhabdomyosarcoma", Virchows Archiv, 456, pp.463~472 (2010)[DOI]
10. Keller C, "Mechanisms of impaired differentiation in rhabdomyosarcoma", FEBS J, 280, pp.4323~4334 (2013)[DOI]
11. Sultan I, "Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients", J Clin Oncol, 27, pp.3391~3397 (2009)[DOI]
12. Hosoi H, "A review of 331 rhabdomyosarcoma cases in patients treated between 1991 and 2002 in Japan", Int J Clin Oncol, 12, pp.137~145 (2007)[DOI]
13. Weiss AR, "Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee", J Clin Oncol, 31, pp.3226~3232 (2013)[DOI]
14. Ognjanovic S, "Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005", Cancer, 115, pp.4218~4226 (2009)[DOI]
15. Schmitt-Ney M, "The PAX3-FOXO1 fusion protein present in rhabdomyosarcoma interferes with normal FOXO activity and the TGF-<TEX>${\beta}$<", TEX> pathway, 2015, pp.10, e0121474~
16. Barr FG, "Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions", Cancer Res, 62, pp.4704~4710 (2002)
17. Sumegi J, "Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator (NCOA) family", Genes Chromosomes Cancer, 49, pp.224~236 (2010)

관련 논문AI추천